Alnylam’s HELIOS-B Review: Conflicting Insights Analyzed by Lilu Anderson 25.06.2024 Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.
Teladoc Health Vs. Novavax: Stock Picks and Avoidance by Mark Eisenberg 09.04.2024 Teladoc Health's revenue grew by 8% to $2.6 billion in 2023, with a gross margin of 70.8%. On the other ...
Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Hold by Terry Bingman 06.04.2024 Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
Misr University for Science and Technology to Host International Biotechnology Conference by Lilu Anderson 04.03.2024 The Third International Biotechnology Conference at Misr University for Science and Technology aims to address environmental and health challenges.
GSK and Elegen Partner to Bolster R&D with DNA Tech by Lilu Anderson 24.01.2024 GSK and Elegen partner to develop new vaccines and medicines, harnessing Elegen's DNA manufacturing technology. Collaboration aims to expand genetic ...